| Differences in expansion potential of naive chimeric antigen receptor T cells from healthy donors and untreated chronic lymphocytic leukemia patients JM Hoffmann, ML Schubert, L Wang, A Hückelhoven, L Sellner, S Stock, ... Frontiers in immunology 8, 1956, 2018 | 104 | 2018 |
| Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients S Stock, R Übelhart, ML Schubert, F Fan, B He, JM Hoffmann, L Wang, ... International journal of cancer 145 (5), 1312-1324, 2019 | 74 | 2019 |
| Chimeric antigen receptor transduced T cells: Tuning up for the next generation ML Schubert, JM Hoffmann, P Dreger, C Müller‐Tidow, M Schmitt International journal of cancer 142 (9), 1738-1747, 2018 | 61 | 2018 |
| Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in haematological malignancies using biosimilar G‐CSF M Schmitt, JM Hoffmann, K Lorenz, A Publicover, A Schmitt, A Nagler Vox sanguinis 111 (2), 178-186, 2016 | 47 | 2016 |
| Chimeric antigen receptor T cell therapy targeting CD19-positive leukemia and lymphoma in the context of stem cell transplantation ML Schubert, A Hückelhoven, JM Hoffmann, A Schmitt, P Wuchter, ... Human Gene Therapy 27 (10), 758-771, 2016 | 46 | 2016 |
| Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells W Gong, JM Hoffmann, S Stock, L Wang, Y Liu, ML Schubert, B Neuber, ... Cancer Immunology, Immunotherapy 68, 1195-1209, 2019 | 45 | 2019 |
| Influence of retronectin-mediated T-cell activation on expansion and phenotype of CD19-specific chimeric antigen receptor T cells S Stock, JM Hoffmann, ML Schubert, L Wang, S Wang, W Gong, B Neuber, ... Human Gene Therapy 29 (10), 1167-1182, 2018 | 24 | 2018 |
| Modulation of B cells and homing marker on NK cells through extracorporeal photopheresis in patients with steroid-refractory/resistant graft-vs.-host disease without hampering … L Wang, M Ni, A Hückelhoven-Krauss, L Sellner, JM Hoffmann, B Neuber, ... Frontiers in immunology 9, 2207, 2018 | 22 | 2018 |
| Tumor-specific reactive oxygen species accelerators improve chimeric antigen receptor T cell therapy in B cell malignancies HJ Yoo, Y Liu, L Wang, ML Schubert, JM Hoffmann, S Wang, B Neuber, ... International journal of molecular sciences 20 (10), 2469, 2019 | 18 | 2019 |
| Next-generation dendritic cell-based vaccines for leukemia patients JM Hoffmann, M Schmitt, M Ni, A Schmitt Immunotherapy 9 (2), 173-181, 2017 | 12 | 2017 |
| Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interface R Ludwig, JM Hoffmann, B Pouymayou, MB Däppen, G Morand, ... Radiotherapy and Oncology 169, 1-7, 2022 | 9 | 2022 |
| Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies M Ni, JM Hoffmann, M Schmitt, A Schmitt Expert opinion on biological therapy 16 (9), 1113-1123, 2016 | 9 | 2016 |
| The carbon footprint of clinical trials: a global survey on the status quo and current regulatory guidance JM Hoffmann, A Bauer, R Grossmann BMJ Global Health 8 (9), e012754, 2023 | 5 | 2023 |
| A dataset on patient-individual lymph node involvement in oropharyngeal squamous cell carcinoma R Ludwig, JM Hoffmann, B Pouymayou, G Morand, MB Däppen, ... Data in Brief 43, 108345, 2022 | 4 | 2022 |
| Academic clinical trials: Publication of study results on an international registry—We can do better! JM Hoffmann, R Grossmann, A Widmann Frontiers in Medicine 9, 1069933, 2022 | 3 | 2022 |
| MO-0877 Predicting bilateral involvement in head & neck cancer using an interpretable probabilistic model R Ludwig, B Pouymayou, J Hoffmann, P Balermpas, J Unkelbach Radiotherapy and Oncology 170, S764-S765, 2022 | 1 | 2022 |
| No inhibition of anti-viral and anti-leukemia effects by extracorporeal photopheresis therapy NI Ming, L Wang, A Hückelhoven, L Sellner, B Neuber, JM Hoffmann, ... Blood 132, 3399, 2018 | 1 | 2018 |
| Modelling the lymphatic metastatic progression pathways of OPSCC from multi-institutional datasets R Ludwig, AD Schubert, D Barbatei, L Bauwens, JM Hoffmann, S Werlen, ... Scientific Reports 14 (1), 15750, 2024 | | 2024 |
| Toward a global harmonization of service infrastructure in academic clinical trial units: an international survey JM Hoffmann, A Blümle, R Grossmann, H Yau, B Lang, C Bradbury Frontiers in Medicine 10, 1252352, 2023 | | 2023 |
| OC-0087 A complete bilateral model of lymphatic progression in HNSCC trained with multicentric patient data R Ludwig, J Hoffmann, B Pouymayou, L Franceschetti, L Bauwens, ... Radiotherapy and Oncology 182, S50-S51, 2023 | | 2023 |
